Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...

The results from the genetic testing can identify an increased risk of cancer even if the individual did not know they were ...

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on ...

Circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based ...

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

Shifts in Medicare spending for patients with cancer undergoing chemotherapy following implementation of the Maryland Global Budget Revenue program. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Specialists say one of the most powerful aspects of genetic screening is that it often identifies high-risk individuals long ...

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer ...